Development and applications of VSV vectors based on cell tropism

Frontiers in Microbiology

Volumn 2, Issue JAN, 2012, Pages

  Tani, Hideki ^a   Morikawa, Shigeru ^a   Matsuura, Yoshiharu ^b  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

Entry mechanism; Pseudotype; Recombinant; Vesicular stomatitis virus

Indexed keywords

ANIMALIA; HEPATITIS C VIRUS; JAPANESE ENCEPHALITIS VIRUS; VESICULAR STOMATITIS VIRUS;

EID: 84870595664     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2011.00272     Document Type: Article

References (57)

1. Bartosch, B., Dubuisson, J., and Cosset, E L. (2003). Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes. J. Exp. Med. 197, 633-642.
2. Blanchard, E., Belouzard, S., Goueslain, L., Wakita, T., Dubuisson, J., Wychowski, C., and Rouillé, Y. (2006). Hepatitis C virus entry depends on clathrin-mediated endocytosis. J. Virol. 80, 6964-6972.
3. Boonsanay, V., and Smith, D. R. (2007). Entry into and production of the Japanese encephalitis virus from C6/36 cells. Intervirology 50, 85-92.
4. Boritz, E., Gerlach, J., Johnson, J. E., and Rose, J. K. (1999). Replication-competent rhabdoviruses with human immunodeficiency virus type 1 coats and green fluorescent protein: entry by a pH-independent pathway. J. Virol. 73, 6937-6945.
5. Boyce, E M., and Bucher, N. L. (1996). Baculovirus-mediated gene transfer into mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 93, 2348-2352.
6. Cerny, A., and Chisari, E V. (1999). Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence. Hepatology 30,595-601.
7. Cobleigh, M. A., Buonocore, L., Uprichard, S. L., Rose, J. K., and Robek, M. D. (2010). A vesicular stomatitis virus-based hepatitis B virus vaccine vector provides protection against challenge in a single dose. J. Virol. 84, 7513-7522.
8. Das, S., Laxminarayana, S. V., Chandra, N., Ravi, V., and Desai, A. (2009). Heat shock protein 70 on Neuro2a cells is a putative receptor for Japanese encephalitis virus. Virology 385, 47-57.
9. Das, S., Ravi, V., and Desai, A. (2011). Japanese encephalitis virus interacts with vimentin to facilitate its entry into porcine kidney cell line. Virus Res. 160,404-408.
10. Fukushi, S., Mizutani, T., Saijo, M., Kurane, I., Taguchi, F., Tashiro, M., and Morikawa, S. (2006). Evaluation of a novel vesicular stomatitis virus pseudotype-based assay for detection of neutralizing antibody responses to SARS-CoV. J. Med. Virol. 78, 1509-1512.
11. Fukushi, S., Mizutani, T., Saijo, M., Matsuyama, S., Miyajima, N., Taguchi, F., Itamura, S., Kurane, I., and Morikawa, S. (2005). Vesicular stomatitis virus pseudotyped with severe acute respiratory syndrome coron-avirus spike protein.J. Gen. Virol. 86, 2269-2274.
12. Garbutt, M., Liebscher, R., Wahl-Jensen, V., Jones, S., Möller, P., Wagner, R., Volchkov, V., Klenk, H. D., Feldmann, H., and Ströher, U. (2004). Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses. J. Virol. 78, 5458-5465.
13. Gubler, D., Kuno, G., and Markoff, L. (2007)."Flaviviruses, 1153-1252," in Fields Virology, 5th Edn, Vol. 1, eds D. M. Knipe and P. M. Howley (Philadelphia, PA: Lippincott-Williams &Wilkins), 1153-1252.
14. Hofmann, C., Sandig, V., Jennings, G., Rudolph, M., Schlag, P., and Strauss, M. (1995). Efficient gene transfer into human hepatocytes by baculovirus vectors. Proc. Natl. Acad. Sci. U.S.A. 92, 10099-10103.
15. Hofmann, C., and Strauss, M. (1998). Baculovirus-mediated gene transfer in the presence of human serum or blood facilities by inhibition of the complement system. Gene Ther. 5, 531-536.
16. Hsu, M., Zhang, J., Flint, M., Logvinoff, C., Cheng-Mayer, C., Rice, C.M., and McKeating, J. A. (2003). Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles. Proc. Natl. Acad. Sci. U.S.A. 100, 7271-7276.
17. Huang, A. S., Palma, E. L., Hewlett, N., and Roizman, R. (1974). Pseudotype formation between enveloped RNA and DNA viruses. Nature 252, 743-745.
18. Ishii, K., Murakami, K., Hmwe, S. S., Zhang, B., Li, J., Shirakura, M., Morikawa, K., Suzuki, R., Miyamura, T., Wakita, T., and Suzuki, T. (2008). Trans-encapsidation of hepatitis C virus subgenomic replicon RNA with viral structure proteins. Biochem. Biophys. Res. Commun. 371,446-450.
19. Iyer, A. V., Pahar, B., Boudreaux, M. J., Wakamatsu, N., Roy, A. F., Chouljenko, V N., Baghian, A., Apetrei, C., Marx, P. A., and Kousoulas, K. G. (2009). Recombinant vesicular stomatitis virus-based West Nile vaccine elicits strong humoral and cellular immune responses and protects mice against lethal challenge with the virulent West Nile virus strain LSU-AR01. Vaccine 27, 893-903.
20. Kahn, J. S., Roberts, A., Weibel, C., Buonocore, L., and Rose, J. K. (2001). Replication-competent or attenuated, nonpropagating vesicular stomatitis viruses expressing respiratory syncytial virus (RSV) antigens protect mice against RSV challenge.J. Virol. 75, 11079-11087.
21. Kaku, Y., Noguchi, A., Marsh, G. A., McEachern, J. A., Okutani, A., Hotta, K., Bazartseren, B., Fukushi, S., Broder, C. C., Yamada, A., Inoue, S., and Wang, L. E (2009). A neutralization test for specific detection of Nipah virus antibodies using pseudotyped vesicular stomatitis virus expressing green fluorescent protein. J. Virol. Methods. 160, 7-13.
22. Kaname, Y., Tani, H., Kataoka, C., Shiokawa, M., Taguwa, S., Abe, T., Moriishi, K., Kinoshita, T., and Matsuura,Y. (2010). Acquisition of complement resistance through incorporation of CD55/decay-accelerating factor into viral particles bearing baculovirus GP64. J. Virol. 84, 3210-3219.
23. Kang, Y., Xie, L., Tran, D. T., Stein, C. S., Hickey, M., Davidson, B. L., and McCray, P. B. Jr. (2005). Persistent expression of factor VIII in vivo following nonprimate lentiviral gene transfer. Blood 106, 1552-1558.
24. Kumar, M., Bradow, B. P., and Zimmerberg, J. (2003). Large-scale production of pseudotyped lentiviral vectors using baculovirus GP64. Hum. Gene Ther. 14, 67-77.
25. Lagging, L. M., Meyer, K., Owens, R. J., and Ray, R. (1998). Functional role of hepatitis C virus chimeric glycoproteins in the infectivity of pseudo-typed virus. J. Virol. 72, 3539-3546.
26. Lee, C. J., Lin, H. R., Liao, C. L., and Lin, Y L. (2008). Cholesterol effectively blocks entry of flavivirus. J. Virol. 82, 6470-6480.
27. Lee, E., and Lobigs, M. (2002). Mechanism of virulence attenuation of glycosaminoglycan-binding variants of Japanese encephalitis virus and Murray Valley encephalitis virus. J. Virol. 76,4901-4911.
28. Lee, B. H., Yoshimatsu, K., Araki, K., Okumura, M., Nakamura, I., and Arikawa, J. (2006). A pseudotype vesicular stomatitis virus containing Hantaan virus envelope glycoproteins G1 and G2 as an alternative to hantavirus vaccine in mice. Vaccine 24, 2928-2934.
29. Lohmann, V, Korner, F., Koch, J., Herian, U., Theilmann, L., and Barten-schlager, R. (1999). Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285, 110-113.
30. Ma, Y., and Li, J. (2011). Vesicular stomatitis virus as a vector to deliver virus-like particles of human norovirus: a new vaccine candidate against an important noncultivable virus. J. Virol. 85, 2942-2952.
31. Matsuura, Y., Tani, H., Suzuki, K., Kimura-Someya, T., Suzuki, R., Aizaki, H., Ishii, K., Moriishi, K., Robison, C. S., Whitt, M. A., and Miyamura, T. (2001). Characterization of pseudotype VSV possessing HCV envelope proteins. Virology 286,263-275.
32. Muik, A., Kneiske, I., Werbizki, M., Wil-flingseder, D., Giroglou, T., Ebert, O., Kraft, A., Dietrich, U., Zimmer, G., Momma, S., and von Laer, D. (2011). Pseudotyping vesicular stomatitis virus with lymphocytic choriomeningitis virus glycoproteins enhances infectivity for glioma cells and minimizes neurotropism. J. Virol. 85, 5679-5684.
33. Nakauchi, M., Fukushi, S., Saijo, M., Mizutani, T., Ure, A. E., Romanowski, V., Kurane, I., and Morikawa, S. (2009). Characterization of monoclonal antibodies to Junin virus nucleocapsid protein and application to the diagnosis of hemorrhagic fever caused by South American arenaviruses. Clin. Vaccine Immunol. 16, 1132-1138.
34. Okuma, K., Matsuura, Y., Tatsuo, H., Inagaki, Y., Nakamura, M., Yamamoto,N.,and Yanagi,Y. (2001). Analysis of the molecules involved in human T-cell leukemia virus type 1 entry by a vesicular stomatitis virus pseudotype bearing its envelope glycoproteins. J. Gen. Virol. 82, 821-830.
35. Perez, M., Watanabe, M., Whitt, M. A., and de la Torre, J. C. (2001). N-terminal domain of Borna disease virus G (p56) protein is sufficient for virus receptor recognition and cell entry. J. Virol. 75, 7078-7085.
36. Publicover, J., Ramsburg, E., and Rose, J. K. (2005). A single-cycle vaccine vector based on vesicular stomatitis virus can induce immune responses comparable to those generated by a replication-competent vector. J. Virol. 79, 13231-13238.
37. Ren, J., Ding, T., Zhang, W., Song, J., and Ma, W (2007). Does Japanese encephalitis virus share the same cellular receptor with other mosquito-borne flaviviruses on the C6/36 mosquito cells? Virol. J. 4, 83.
38. Roberts, A., Kretzschmar, E., Perkins, A. S., Forman, J., Price, R., Buonocore, L., Kawaoka, Y., and Rose, J. K. (1998). Vaccination with a recombinant vesicular stomatitis virus expressing an influenza virus hemagglutinin provides complete protection from influenza virus challenge. J. Virol. 72, 4704-4711.
39. Roberts, A., Reuter, J. D., Wilson, J. H., Baldwin, S., and Rose, J. K. (2004). Complete protection from papillomavirus challenge after a single vaccination with a vesicular stomatitis virus vector expressing high levels of L1 protein. J. Virol. 78, 3196-3199.
40. Saha, M. N., Tanaka, A., JinnoOue, A., Shimizu, N., Tamura, K., Shinagawa, M., Chiba, J., and Hoshino, H. (2005). Formation of vesicular stomatitis virus pseudotypes bearing surface proteins of hepatitis B virus. J. Virol. 79, 12566-12574.
41. Schauber, C. A., Tuerk, M. J., Pacheco, C. D., Escarpe, P. A., and Veres, G. (2004). Lentiviral vectors pseudotyped with baculovirus gp64 efficiently transduce mouse cells in vivo and show tropism restriction against hematopoietic cell types in vitro. Gene Ther. 11, 266-275.
42. Schnell, M. J., Buonocore, L., Kretzschmar, E., Johnson, E., and Rose, J. K. (1996). Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses are incorporated efficiently into virus particles. Proc. Natl. Acad. Sci. U.S.A. 93, 11359-11365.
43. Shoji, I., Aizaki, H., Tani, H., Ishii, K., Chiba, T., Saito, I., Miyamura, T., and Matsuura, Y. (1997). Efficient gene transfer into various mammalian cells, including non-hepatic cells, by baculovirus vectors. J. Gen. Virol. 78,2657-2664.
44. Sinn, P. L., Arias, A. C., Brogden, K. A., and McCray, P. B. Jr. (2008). Lentivirus vector can be readministered to nasal epithelia without blocking immune responses. J. Virol. 82, 10684-10692.
45. Sinn, P. L., Burnight, E. R., Hickey, M. A., Blissard, G. W., and McCray, P. B. Jr. (2005). Persistent gene expression in mouse nasal epithelia following feline immunodeficiency virus-based vector gene transfer. J. Virol. 79,12818-12827.
46. Steinmann, E., Brohm, C., Kallis, S., Bartenschlager, R., and Pietschmann, T. (2008). Efficient transencapsidation of hepatitis C virus RNAs into infectious virus-like particles. J. Virol. 82, 7034-7046.
47. Su, C. M., Liao, C. L., Lee, Y L., and Lin, Y L. (2001). Highly sulfated forms of heparin sulfate are involved in Japanese encephalitis virus infection. Virology 286, 206-215.
48. Takada, A., Robison, C., Goto, H., Sanchez, A., Murti, K. G., Whitt, M. A., and Kawaoka, Y. (1997). A system for functional analysis of Ebola virus glycoprotein. Proc. Natl. Acad. Sci. USA. 94, 14764-14769.
49. Tani, H., Komoda, Y., Matsuo, E., Suzuki, K., Hamamoto, I., Yamashita, T., Moriishi, K., Fujiyama, K., Kanto, T., Hayashi, N., Owsianka, A., Patel, A. H., Whitt, M. A., and Matsuura, Y (2007). Replication-competent recombinant vesicular stomatitis virus encoding hepatitis C virus envelope proteins. J. Virol. 81, 8601-8612.
50. Tani, H., Limn, C. K., Yap, C. C., Onishi, M., Nozaki, M., Nishimune, Y., Okahashi, N., Kitagawa, Y., Watanabe, R., Mochizuki, R., Moriishi, K., and Matsuura, Y (2003). In vitro and in vivo gene delivery by recombinant baculoviruses. J. Virol. 77, 9799-9808.
51. Tani, H., Nishijima, M., Ushijima, H., Miyamura, T., and Matsuura, Y. (2001). Characterization of cell-surface determinants important for baculovirus infection. Virology 279, 343-353.
52. Tani, H., Shiokawa, M., Kaname, Y., Kambara, H., Mori, Y., Abe, T., Moriishi, K., and Matsuura, Y. (2010). Involvement of ceramide in the propagation of Japanese encephalitis virus. J. Virol. 84, 2798-2807.
53. Tatsuo, H., Okuma, K., Tanaka, K., Ono, N., Minagawa, H., Takade, A., Matsuura, Y., and Yanagi, Y (2000). Virus entry is a major determinant of cell tropism of Edmonston and wild-type strains of measles virus as revealed by vesicular stomatitis virus pseudotypes bearing their envelope proteins.J. Virol. 74,4139-4145.
54. Theodore, D., and Fried, M. W (2000). Natural history and disease manifestations of hepatitis C infection. Curr. Top. Microbiol. Immunol. 242, 43-54.
55. Vela, E. M., Zhang, L., Colpitts, T. M., Davey, R. A., and Aronson, J. F. (2007). Arenavirus entry occurs through a cholesterol-dependent, non-caveolar, clathrin-mediated endocytic mechanism. Virology 369, 1-11.
56. Whitt, M. A. (2010). Generation of VSV pseudotypes using recombinant ΔG-VSV for studies on virus entry, identification of entry inhibitors, and immune responses to vaccines. J. Virol. Methods 169, 365-374.
57. Witte, O. N., and Baltimore, D. (1977). Mechanism of formation of pseudotypes between vesicular stomatitis virus and murine leukemia virus. Cell 11, 505-511.